EUVIMEDEUVIMED entdecken
Crossref

Dipeptidyl peptidase 3 is essential for maintaining osteoblastic differentiation under a high-glucose environment by inhibiting apoptosis, oxidative stress and inflammation through the modulation of the Keap1-Nrf2 pathway

Xiaofeng Li, Xiangyou Yu, Shenglin He, Jing Li

International Immunopharmacology · 2023-07 · 120 · 110404

DOI: 10.1016/j.intimp.2023.110404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023-07. Verfasst von Xiaofeng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology Diabetes, Shaanxi Provincial People's Hospital, Xi'an 710068, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Osteoporosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Shanxi Provincial Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dipeptidyl peptidase 3 (Dpp3) has emerged as a pivotal mediator of bone homeostasis and bone loss pathology. However, whether Dpp3 plays a role in diabetic osteoporosis has not been addressed. Therefore, this work explored the possible role of Dpp3 in osteoblast dysfunction evoked by high glucose (HG), a cellular model for studying diabetic osteoporosis in vitro. Dpp3 expression was decreased in the pre-osteoblast MC3T3-E1 during osteoblastic differentiation under the HG environment. The osteoblastic differentiation impaired by HG was reversed in Dpp3-overexpressing MC3T3-E1 cells. The migration and invasion of MC3T3-E1 cells impeded by HG were reversed by Dpp3 overexpression. Moreover, HG-evoked apoptosis, oxidative stress and inflammation were ameliorated in Dpp3-overexpressing MC3T3-E1 cells. A mechanistic study showed that Dpp3 up-regulated the activation of nuclear factor E2-related factor 2 (Nrf2) depending on Kelch-like ECH-associated protein 1 (Keap1). The blockade of Nrf2 reversed Dpp3-mediated effects on osteoblastic differentiation, apoptosis, oxidative stress and inflammation of HG-stimulated MC3T3-E1 cells. Therefore, Dpp3 plays an essential role in maintaining osteoblastic differentiation under a HG environment associated with the regulation of the Keap1-Nrf2 pathway. This work indicates a possible relationship between Dpp3 and diabetic osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2OsteoporosisHumansKelch-Like ECH-Associated Protein 1Signal TransductionOxidative StressCell DifferentiationOsteoblastsApoptosisInflammationGlucoseDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Stichwörter der Autor:innen

Diabetic osteoporosisDpp3Nrf2OsteoblastOsteoblastic differentiation

Substanzen

Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2GlucoseDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Autor:innen und Institutionen

  • Department of Endocrinology Diabetes, Shaanxi Provincial People's Hospital, Xi'an 710068, China.
  • Department of Endocrinology Diabetes, Shaanxi Provincial People's Hospital, Xi'an 710068, China. Electronic address: ljn_fm1030@163.com.

Förderung

  • Shanxi Provincial Key Research and Development Project

Zitieren

APA

Li, X., Yu, X., He, S., & Li, J. (2023). Dipeptidyl peptidase 3 is essential for maintaining osteoblastic differentiation under a high-glucose environment by inhibiting apoptosis, oxidative stress and inflammation through the modulation of the Keap1-Nrf2 pathway. International Immunopharmacology, 120, 110404. https://doi.org/10.1016/j.intimp.2023.110404

Vancouver

Li X, Yu X, He S, Li J. Dipeptidyl peptidase 3 is essential for maintaining osteoblastic differentiation under a high-glucose environment by inhibiting apoptosis, oxidative stress and inflammation through the modulation of the Keap1-Nrf2 pathway. International Immunopharmacology. 2023;120:110404. doi:10.1016/j.intimp.2023.110404

BibTeX
@article{Li2023,
  author = {Li, Xiaofeng and Yu, Xiangyou and He, Shenglin and Li, Jing},
  title = {Dipeptidyl peptidase 3 is essential for maintaining osteoblastic differentiation under a high-glucose environment by inhibiting apoptosis, oxidative stress and inflammation through the modulation of the Keap1-Nrf2 pathway},
  journal = {International Immunopharmacology},
  year = {2023},
  volume = {120},
  pages = {110404},
  doi = {10.1016/j.intimp.2023.110404}
}
Kostenlos starten →